IDO1 and neoplasm: Using subtherapeutic doses of IDO-targeting Salmonella, they observed an increase in the antigen presentation machinery and costimulatory molecules in intratumoral myeloid cells, decrease in the frequency of Tregs in LLC1 tumor microenvironment and inhibition in the expression of inhibitory immune checkpoint ligands on splenic immune cells.